Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.
Smeesters
C
C
Department of Surgery, Notre-Dame Hospital, Montreal, Québec, Canada.
Chaland
P
P
Giroux
L
L
Moutquin
J M
JM
Etienne
P
P
Douglas
F
F
Corman
J
J
St-Louis
G
G
Daloze
P
P
D015121:6-Ketoprostaglandin F1 alpha / Q000652:urine; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000037:antagonists & inhibitors* / Q000097:blood; D015232:Dinoprostone; D007668:Kidney / Q000187:drug effects*; D011458:Prostaglandins E / Q000652:urine; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D013929:Thromboxane B2 / Q000652:urine; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D003524:Cyclosporins; D011458:Prostaglandins E; D011725:Pyridines; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; C049113:3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid; D003404:Creatinine; D013930:Thromboxane-A Synthase; D015232:Dinoprostone